This finding is particularly significant as a study conducted in adolescents with T1D (40% with BMI in the 90th percentile) reported improvements in insulin sensitivity, as well as aortic and carotid health, along with reductions in body weight, fat mass, and insulin dose after three months of metformin use [23]. The gene discussed is INS; the disease is type 1 diabetes mellitus.